Avanos Medical, Inc. (AVNS) is a publicly traded Healthcare sector company. As of May 21, 2026, AVNS trades at $24.74 with a market cap of $1.16B and a P/E ratio of -2.90. AVNS moved -0.04% today. Year to date, AVNS is +118.74%; over the trailing twelve months it is +88.86%. Its 52-week range spans $9.30 to $24.91. Rallies surfaces AVNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AVNS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AVNS recently traded at $24.74. Market cap is $1.16B. P/E ratio is -2.90. Revenue is $687.80M.
| Metric | Value |
|---|---|
| Price | $24.74 |
| Market Cap | $1.16B |
| P/E Ratio | -2.90 |
| EPS | $-8.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.91 |
| 52-Week Low | $9.30 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $687.80M |
| Net Income | $-392.10M |
| Gross Margin | 55.44% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $687.80M | $-392.10M | $-8.53 |
| 2023 | $673.30M | $-61.80M | $-1.32 |
| 2022 | $820.00M | $50.50M | $1.08 |
| 2021 | $744.60M | $5.20M | $0.11 |
AVNS analyst coverage data. Average price target: $0.00.